Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/585366


Booming US Generic Drug Market


Description: The US is the largest pharmaceutical markets in the world. Driven by factors, such as large healthcare spending, high per-capita income, and strong investments, the pharmaceutical market in the US has been witnessing an upward surge. Despite recession, the market continued to perform in an effective manner. Generics too have enlarged their share in the overall pharmaceutical market, in terms of both revenue and prescriptions. The US generic drugs market has been growing at a fast pace on the back of factors, such as demand for cost-effective medications, patent expiration of blockbuster drugs, and the government support.

The US generics market is anticipated to grow at a CAGR of around 10% during 2010-2013, says our recent research report “Booming US Generic Drug Market”. Currently, the market is witnessing significant developments in the form of new product categories that are attracting huge investments from both public and private players. The US government has welcomed their arrivals and extended support in the form of approvals and incentives. In terms of future scenario, major pharmaceutical players are likely to spend heavily on research and development as present market is in dynamic in nature and requires innovative products. Besides, these players will be consistently reviewing patent regime as through proactive approach, they will be able to launch their drugs first.

The generics market in the US has good growth potential in various therapy segments, which have attracted investments and market revenue in recent times. In this regard, our report provides rational analysis of various factors, which will drive the generics market in the US during the forecast period.

Overall, the report covers all the important aspects of the US generics market and provides an in-depth analysis on emerging trends, such as injectable generics, anti-counterfeit coalition, and bio-generics among others. It also provides valuable information to pharmaceutical & generics companies and investors looking to enter this market. Facts and figures regarding market size, growth, share, regulatory environment, and trends in technology development have been thoroughly analyzed in the report to provide clients a comprehensive overview of the market.


Contents: 1. Analyst View

2. Research Methodology

3. Market Overview

4. Industry Performance and Forecast to 2013
4.1 Branded vs Generics
4.2 Generics Drugs Market
4.2.1 By Value
4.2.2 By Volume

5. Market Potential of Generics Drugs in Key Therapies Segments
5.1 Lipid Regulators
5.2 Antipsychotics
5.3 Angiotensin II Receptor
5.4 Anti Depressants
5.5 Human Insulin
5.6 Proton Pump Inhibitors
5.7 Erythropoietin

6. Regulatory Environment
6.1 Drug Efficacy Study Implementation (DESI) Program
6.2 Hatch-Waxman Act
6.3 Patent Infringement Litigations
6.4 Para IV & the 180-day Marketing Exclusivity
6.5 FDA Requirements
6.6 Generic Initiative for Value & Efficiency (GIVE)
6.7 Healthcare Bill 2010
6.8 Ban on “Pay for delay” Settlements
6.9 Patient Protection and Affordable Care Act

7. Emerging Market Trends
7.1 Biogenerics/Biosimilar
7.2 Anti-counterfeit Coalition
7.3 Injectable Generics
7.4 Patent Expiration
7.5 Asthma & COPD Drugs

8. Key Players
8.1 Teva Pharmaceuticals USA
8.2 Watson Pharmaceuticals, Inc.
8.3 Mylan Laboratories Inc.
8.4 Pfizer Inc.
8.5 Sandoz Inc. (Novartis)

List of Tables

Table 5-1: Top Therapeutic Categories by Sales (Billion US$), 2009
Table 5-2: Patent Expiration of Key Lipid Regulators
Table 5-3: Patent Expiration of Key Antipsychotic Drugs
Table 5-4: Patent Expiration of Key Angiotensin II Receptor
Table 5-5: Patent Expiration of Key Antidepressants Drugs
Table 5-6: Patent Expiration of Key Human Insulin Drugs
Table 5-7: Patent Expiration of Key Proton Pump Inhibitors
Table 7-1: Patent Expiration for Biopharmaceuticals
Table 7-2: Blockbuster Drugs Going Off-patent Globally (2010 to 2012)

List of Charts

Figure 4-1: Share of Branded and Generics Drugs in Prescription Market (2008 & 2009)
Figure 4-2: Generics Drugs Market (Billion US$), 2009-2013
Figure 4-3: Share of Generics and Branded Drugs in Pharma Market (By Sales Value), 2009
Figure 4-4: Share of Generics and Branded Drugs in Prescription Market (By Sales Volume), 2009
Figure 6-1: Generic Drugs Approval Process
Figure 7-1: Biogenerics Market (Billion US$), 2008 & 2013
Figure 7-2: Forecast for Share of Biogenerics Market by Drugs Type (2016)
Figure 8-1: Share of Key Players in Generics Market


Companies Mentioned - Teva Pharmaceuticals USA - Watson Pharmaceuticals, Inc. - Mylan Laboratories Inc. - Pfizer Inc. - Sandoz Inc. (Novartis)


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/585366

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 12/02/2012 13:29:28
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Booming US Generic Drug Market
Web Address:
http://www.researchandmarkets.com/reports/585366
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €764.00
CD ROM €917.00 + EUR€ 50.00 Shipping/Handling *
Hard Copy €917.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Enterprisewide €1,223.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 12/02/2012 13:29:28

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)